COVID-19 Healthcare Inequity: Lessons Learned from Annual Influenza Vaccination Rates to Mitigate COVID-19 Vaccine Disparities
- PMID: 34602888
- PMCID: PMC8461587
COVID-19 Healthcare Inequity: Lessons Learned from Annual Influenza Vaccination Rates to Mitigate COVID-19 Vaccine Disparities
Abstract
The COVID-19 pandemic has infected 33 million Americans and resulted in more than 600,000 deaths as of late Spring 2021. Black, Indigenous, and Latinx (BIL) people are disproportionately infected, hospitalized, and dying. Effective vaccines were rapidly developed and have been widely available in the United States since their initial rollout in late 2020-early 2021 but vaccination rates in BIL communities have remained low compared with non-BIL communities. Limited access to the vaccine, lack of customized information, and mistrust of the medical system, all contribute to vaccine hesitancy and low vaccination rates. Regrettably, COVID-19 is not the only vaccine-preventable illness with racial/ethnic inequities. Similar inequities are seen with the seasonal influenza vaccine. We review the racial/ethnic health disparities in COVID-19 illness and vaccination rates and what inequities contribute to these disparities. We use evidence from the seasonal influenza vaccination efforts to inform potential strategies to attenuate these inequities. The development of effective and sustainable strategies to improve vaccination rates and reduce factors that result in health inequities is essential in managing current and future pandemics and promoting improved health for all communities.
Keywords: COVID-19; Health Disparities; Health Inequities; Immunization; Influenza.
Copyright ©2021, Yale Journal of Biology and Medicine.
Similar articles
-
The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans.J Natl Med Assoc. 2020 Dec;112(6):681-687. doi: 10.1016/j.jnma.2020.11.001. Epub 2020 Dec 1. J Natl Med Assoc. 2020. PMID: 33276969
-
Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.Vaccine. 2021 Oct 1;39(41):6081-6087. doi: 10.1016/j.vaccine.2021.08.097. Epub 2021 Sep 11. Vaccine. 2021. PMID: 34521551 Free PMC article.
-
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 36274602 Chinese.
-
The importance of seasonal influenza vaccination for people with disabilities during the COVID-19 pandemic.Disabil Health J. 2021 Apr;14(2):101058. doi: 10.1016/j.dhjo.2020.101058. Epub 2020 Dec 24. Disabil Health J. 2021. PMID: 33384278 Free PMC article. Review.
-
[Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Feb 6;56(2):103-107. doi: 10.3760/cma.j.cn112150-20211203-01117. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 34954956 Review. Chinese.
Cited by
-
Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens.Vaccines (Basel). 2022 Apr 12;10(4):593. doi: 10.3390/vaccines10040593. Vaccines (Basel). 2022. PMID: 35455342 Free PMC article. Review.
-
The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications.Innov Pharm. 2022 Dec 12;13(3):10.24926/iip.v13i3.5026. doi: 10.24926/iip.v13i3.5026. eCollection 2022. Innov Pharm. 2022. PMID: 36627916 Free PMC article.
-
Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021.Chest. 2024 Jul;166(1):49-60. doi: 10.1016/j.chest.2024.01.049. Epub 2024 Feb 9. Chest. 2024. PMID: 38342164 Free PMC article.
-
COVID-19: The Pseudo-Environment and the Need for a Paradigm Change.Germs. 2021 Dec 29;11(4):468-477. doi: 10.18683/germs.2021.1283. eCollection 2021 Dec. Germs. 2021. PMID: 35096665 Free PMC article. No abstract available.
-
A qualitative investigation of facilitators and barriers to accessing COVID-19 vaccines among Racialized and Indigenous Peoples in Canada.Hum Vaccin Immunother. 2022 Nov 30;18(6):2129827. doi: 10.1080/21645515.2022.2129827. Epub 2022 Oct 11. Hum Vaccin Immunother. 2022. PMID: 36218335 Free PMC article.
References
-
- CDC. Demographic Trends of COVID-19 cases and deaths in the US reported to the CDC 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical